Cargando…
Testing of VKORC1 and CYP2C9 alleles to guide warfarin dosing: Test Category: Pharmacogenomic (Treatment)
Warfarin is an oral anticoagulant that is widely prescribed to prevent thromboembolic events in persons at increased risk. The optimal dose is difficult to establish because it can vary 10-fold among individuals due to clinical and demographic factors. Testing for variants of the vitamin K epoxide r...
Autor principal: | Grossniklaus, Daurice |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940214/ https://www.ncbi.nlm.nih.gov/pubmed/20877452 http://dx.doi.org/10.1371/currents.RRN1155 |
Ejemplares similares
-
Genetic Testing for CYP450 Polymorphisms to Predict Response to Clopidogrel: current evidence and test availability: Application: Pharmacogenomics
por: Ned, Renée M.
Publicado: (2010) -
CYP2D6 testing to predict response to tamoxifen in women with breast cancer: Pharmacogenomic
por: Dahabreh, Issa, et al.
Publicado: (2010) -
Tumor Gene Expression Profiling in Women with Breast Cancer: Test Category: Prognostic
por: Bellcross, Cecelia, et al.
Publicado: (2010) -
KRAS mutational analysis for colorectal cancer: Application: Pharmacogenomic
por: Wang, Grace, et al.
Publicado: (2010) -
Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test
por: Ned, Renée M., et al.
Publicado: (2011)